Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-08-16
2005-08-16
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007230, C435S810000, C435S007240, C436S015000, C436S086000, C436S064000
Reexamination Certificate
active
06929920
ABSTRACT:
Methods of determining Chronic Obstructive Pulmonary Disease (COPD) severity in patients which comprises measuring the concentration of soluble E-cadherin (sE-cadherin) in the patient's urine and/or blood serum and determining the extent of severity by reference to correlation graphs, a method of treating patients with COPD, methods for determining the responsiveness of said patients to said treatment and a prognostic product for detecting the concentration of sE-cadherin in urine and/or blood serum.
REFERENCES:
patent: 5597725 (1997-01-01), Suzuki
patent: 5895748 (1999-04-01), Johnson et al.
patent: 0 826 774 (1998-04-01), None
patent: 06324046 (1994-11-01), None
patent: 10-174590 (1998-06-01), None
patent: 99/53926 (1999-10-01), None
Bullock et al. Expression of E-Cadherin and alpha, beta and gamma catenin is associated with epithelial shedding in human lung and nose J. Allergy and Clinical Immunology (1998) 101: S111.
Kataymata et al. Soluble Fragments of E-Cadherin cell adhesion molecule increase in urinary excretion of cancer patients, potentially indicating its shedding from epithelial tumor cells. International J. Oncology (1994) 5: 1049-1057 (Abstract).
Cioffi et al Serum-soluble E-cadherin fragments in lung cancer Tumorl (1999) 85: 32-34 (Abstract).
Loveridge et al., American Review of Respiratory Disease, vol. 134 (5), pp. 930-934 (1986).
Banks et al., Journal of Clinical Pathology, vol. 48, pp. 179-180 (1995).
Pittard, et al., British Journal of Anaesthesia, vol 76, pp. 629-631 (1996).
Maguire, et al., European Journal of Cancer, vol. 33, pp. 404-408 (1997).
Griffiths, et al., “Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence,”British Journal of Cancer, 74: 579-584 (1996).
Pasdar, et al., “Inhibition of Junction Assembly in Cultured Epithelial Cells by Hepatocyte Growth Factor/Scatter Factor is Concomitant with Increased Stability and Altered Phosphorylation of the Soluble Junctional Molecules,”Cell Growth&Differentiation, 8: 451-462 (1997).
Damsky, et al., “Identification and Purificationof a Cell Surface Gylcoprotein Mediating Intercelular Adhesion in Embryonic and Adult Tissue,”Cell, 34: 455-466 (1983).
Matsuyoshi, et al., “Soluble E-Cadherin: a novel cutaneous disease marker,”British Journal of Dermatology, 132: 745-749 (1995).
Berglert, et al., “Protein EnvM is the NADH-dependent Enoyl-ACP Reductase (FabI) ofEscherichia coli”, The Journal of Biological Chemistry, 269(8): 5493-5496 (1994).
Cheu Jacob
Fedon Jason C.
Gimmi Edward R.
Glaxo Group Limited
Kinzig Charles M.
LandOfFree
Diagnosis of chronic obstructive pulmonary disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis of chronic obstructive pulmonary disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis of chronic obstructive pulmonary disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3508041